TOTARO, NOEMI
 Distribuzione geografica
Continente #
EU - Europa 80
AS - Asia 45
NA - Nord America 28
SA - Sud America 20
Totale 173
Nazione #
IT - Italia 33
US - Stati Uniti d'America 26
RU - Federazione Russa 25
SG - Singapore 24
BR - Brasile 17
HK - Hong Kong 9
CN - Cina 8
DE - Germania 4
AT - Austria 3
FR - Francia 3
IE - Irlanda 3
NL - Olanda 3
VN - Vietnam 3
AR - Argentina 2
FI - Finlandia 2
GB - Regno Unito 2
MX - Messico 2
BD - Bangladesh 1
LT - Lituania 1
PY - Paraguay 1
SE - Svezia 1
Totale 173
Città #
Singapore 13
Moscow 11
Ashburn 9
Hong Kong 9
Aversa 7
Beijing 7
Dublin 3
Ho Chi Minh City 3
Lentini 3
Messina 3
Munich 3
Vienna 3
Amsterdam 2
Helsinki 2
Huntington Beach 2
Misterbianco 2
New York 2
Rome 2
São Paulo 2
Alegrete 1
Apodaca 1
Avaré 1
Bexley 1
Bom Jesus da Lapa 1
Boston 1
Buffalo 1
Campinas 1
Düsseldorf 1
Feira de Santana 1
Gravataí 1
Juneau 1
La Plata 1
Lauterbourg 1
London 1
Los Angeles 1
Mexico City 1
Mossoró 1
Muniz Ferreira 1
Paulo Afonso 1
Praia Grande 1
Punta Alta 1
Roubaix 1
San Francisco 1
Santa Clara 1
Santa Rita 1
Santana de Parnaíba 1
Schignano 1
St Louis 1
Stockholm 1
São José 1
São José do Rio Preto 1
São Miguel dos Campos 1
Águas Lindas de Goiás 1
Totale 122
Nome #
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 86
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 65
Naringenin-Loaded Solid Lipid Nanoparticles: Physical–Chemical Characterization and In Vitro Antibacterial Activity 29
Cyclodextrin-Based Formulations as a Promising Strategy to Overcome the Blood–Brain Barrier: Historical Overview and Prospects in Glioblastoma Treatment 1
Totale 181
Categoria #
all - tutte 543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20237 0 0 0 0 0 0 0 0 0 0 6 1
2023/202422 1 0 1 1 0 0 0 0 0 1 18 0
2024/202562 6 0 2 4 4 0 3 4 6 7 12 14
2025/202690 9 12 12 16 12 29 0 0 0 0 0 0
Totale 181